查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1888781

美國電療市場規模、佔有率和趨勢分析報告：按治療方法、應用和細分市場預測（2025-2033 年）

U.S. Electrotherapy Market Size, Share & Trends Analysis Report By Therapy Type (Transcutaneous Electrical Nerve Stimulation (TENS), NMES/FES), By Application, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

美國電療市場摘要

2024年美國電療市場規模估計為4.8031億美元，預計2033年將達到6.939億美元。

預計從 2025 年到 2033 年，該市場將以 4.24% 的複合年成長率成長。這一成長歸因於慢性疼痛、肌肉骨骼疾病和運動相關損傷的日益普遍，這些疾病推動了對非侵入性、無藥物疼痛管理解決方案的需求。

人口老化加劇，老年人罹患關節炎、神經病變和術後疼痛的風險更高，也進一步推動了市場成長。此外，攜帶式、穿戴式和智慧電療設備等技術的進步，以及整合數位監測功能的出現，正在提高治療效果和患者便利性。人們越來越偏好居家醫療和復健治療，以及疼痛管理方式向非鴉片類藥物的轉變，持續推動著美國臨床和家庭環境中電療設備的普及。

美國市場另一個主要成長要素是人口快速老化。老年人更容易患上關節炎、神經病變以及中風後行動不便等疾病。根據美國人口普查局預測，到2035年，美國老年人口（65歲及以上）將首次超過兒童人口，這將顯著增加需要長期疼痛管理和肌肉功能管理治療的患者群體。電療在老年護理中應用日益廣泛，用於改善肌肉功能、血液循環和整體活動能力，從而提高老年人的生活品質。此外，美國持續不斷的鴉片類藥物危機也促使人們更加關注非鴉片類鎮痛方案。聯邦政府的舉措，例如美國疾病管制與預防中心（美國）推薦使用非藥物療法治療慢性疼痛的指南，正在鼓勵醫生和患者選擇電療這種更安全、無成癮性的替代療法。

非侵入性、無藥物止痛療法的日益普及是推動美國電療設備市場發展的關鍵因素。隨著鴉片類藥物危機持續蔓延，醫療服務提供者和患者都在尋求比傳統止痛藥更安全的替代方案。電療能夠有效緩解局部疼痛，並避免了鴉片類藥物相關的成癮風險和全身性副作用。美國疾病管制與預防中心 (CDC) 等聯邦政府機構發布的指南，建議使用非藥物療法治療慢性疼痛，進一步加速了醫院、復健中心和居家醫療機構對電療設備的採用。隨著人們對鴉片類藥物相關風險的認知不斷提高，預計對經皮神經電刺激 (TENS) 和神經肌肉電刺激 (NMES) 等電療設備的需求將顯著成長，從而推動美國醫療保健領域向更安全、技術主導的疼痛管理解決方案轉變。

人們對復健療法的日益重視和廣泛應用，透過提升術後護理的整體連續性，間接推動了美國電外科市場的發展。隨著越來越多的患者和醫療專業人員認知到術後復健在加速復健和改善功能預後的重要性，包括使用電外科設備在內的微創手術技術的需求也在不斷成長。電外科技術能夠精準地切割、凝血和止血，同時最大限度地減少熱傷害。這不僅減少了手術創傷，加速了術後康復，也使患者能夠更早開始復健。這些先進的手術技術與以復健為中心的治療方案相結合，促使醫院和手術中心採用最新的電外科系統，以支持更快的癒合、更少的併發症和更高的患者活動能力，最終推動了美國市場的發展。

目錄

第1章調查方法和範圍

第2章執行摘要

第3章美國電療市場變數、趨勢與範圍

  • 市場譜系展望
    • 母市場展望
    • 相關及配套市場展望
  • 市場動態
  • 美國電療市場分析工具
    • 產業分析—波特五力分析
    • PESTEL 分析

第4章：美國電療市場：治療方法的估算與趨勢分析

  • 依治療方法分析美國電療市場的變化
  • 美國電療市場規模及趨勢分析（依治療方法，2021-2033 年）
  • 經皮電刺激（TENS）
  • 干涉聚焦心靈感應（IFT）
  • NMES/FES
  • 其他

第5章：美國電療市場：按應用分類的估算與趨勢分析

  • 按應用領域分析美國電療市場波動
  • 美國電療市場規模及應用趨勢分析（2021-2033）
  • 神經系統疾病
  • 肌肉損傷
  • 發炎
  • 緩解疼痛
  • 其他

第6章 競爭情勢

  • 對主要市場參與企業近期趨勢和影響的分析
  • 公司/競爭對手分類
    • 創新者
  • 供應商概況
    • Key company market share analysis, 2024
    • Zynex Medical
    • BTL Group of Companies
    • Omron Healthcare, Inc.
    • NeuroMetrix, Inc.
    • GymnaUniphy
    • Enovis Corporation
    • Medtronic
    • Omron Healthcare, Inc.
    • Dentis Co., Ltd.
    • Stymco
    • RS Medical
    • Orthofix Medical
Product Code: GVR-4-68040-807-8

U.S. Electrotherapy Market Summary

The U.S. electrotherapy market size was estimated at USD 480.31 million in 2024 and is anticipated to reach USD 693.90 million by 2033, expanding at a CAGR of 4.24% from 2025 to 2033. This growth is attributed to the growing prevalence of chronic pain, musculoskeletal disorders, and sports-related injuries, which have increased the demand for non-invasive and drug-free pain management solutions.

The aging population, which is more prone to arthritis, neuropathy, and post-surgical pain, further fuels market growth. In addition, advancements in technology, such as portable, wearable, and smart electrotherapy devices integrated with digital monitoring, are enhancing treatment efficacy and patient convenience. The rising preference for home healthcare and rehabilitation therapies, combined with the shift away from opioid-based pain management, continues to strengthen the adoption of electrotherapy devices across clinical and home settings in the U.S.

Another key growth driver in the U.S. market is the rapidly aging population, which is highly susceptible to conditions such as arthritis, neuropathy, and post-stroke mobility limitations. The U.S. Census Bureau projects that by 2035, older adults (aged 65 and above) will outnumber children for the first time in U.S. history, creating a substantial patient base requiring long-term pain and muscle management therapies. Electrotherapy is increasingly being adopted in geriatric care to improve muscle function, circulation, and overall mobility, thereby enhancing quality of life. Moreover, the ongoing opioid crisis in the U.S. has strengthened the focus on non-opioid pain management solutions. Federal initiatives, such as the CDC's guidelines promoting non-pharmacological treatments for chronic pain, have further encouraged physicians and patients to opt for electrotherapy as a safer, non-addictive alternative.

The growing shift toward non-invasive and drug-free pain management therapies is a significant factor driving the U.S. electrotherapy device market. With the nation grappling with an ongoing opioid crisis, both healthcare providers and patients are increasingly seeking safer alternatives to traditional pain medications. Electrotherapy offers effective, localized pain relief without the risk of addiction, dependency, or systemic side effects associated with opioids. Federal initiatives, such as the Centers for Disease Control and Prevention (CDC) guidelines promoting non-pharmacological approaches for chronic pain, have further accelerated the adoption of electrotherapy devices across hospitals, rehabilitation centers, and home care settings. As awareness of opioid-related risks continues to rise, the demand for electrotherapy devices, such as Transcutaneous Electrical Nerve Stimulation (TENS) and Neuromuscular Electrical Stimulation (NMES) systems, is expected to grow significantly, supporting the broader shift toward safer, technology-driven pain management solutions in the U.S. healthcare landscape.

The growing awareness and adoption of rehabilitation therapies indirectly drive the U.S. electrosurgery market by enhancing the overall continuum of care following surgical procedures. As more patients and clinicians recognize the importance of post-surgical rehabilitation for faster recovery and improved functional outcomes, the demand for minimally invasive surgical techniques, including those performed with electrosurgical devices, is increasing. Electrosurgery enables precise tissue cutting, coagulation, and hemostasis with minimal thermal damage, which helps reduce surgical trauma and accelerates postoperative recovery, allowing patients to begin rehabilitation sooner. This alignment between advanced surgical methods and rehabilitation-focused treatment pathways encourages hospitals and surgical centers to adopt modern electrosurgical systems that support quicker healing, fewer complications, and improved patient mobility, ultimately fueling market growth in the U.S.

U.S. Electrotherapy Market Report Segmentation

This report forecasts revenue growth at the country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For the purpose of this study, Grand View Research has segmented the U.S. electrotherapy market report on the basis of therapy type and application:

  • Therapy Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Transcutaneous Electrical Nerve Stimulation (TENS)
  • Interferential Therapy (IFT)
  • NMES/FES
  • Others
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Nervous Disease
  • Muscle Injury
  • Inflammation
  • Pain Relief
  • Others

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Therapy Type
    • 1.1.2. Application
    • 1.1.3. Estimates And Forecast Timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources
    • 1.3.4. Primary Research
    • 1.3.5. Details Of Primary Research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity Price Analysis (Model 1)
    • 1.6.2. Approach 1: Commodity Flow Approach
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Electrotherapy Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising prevalence of chronic pain and musculoskeletal disorders
      • 3.2.1.2. Increasing geriatric population
      • 3.2.1.3. Growing adoption of non-invasive and drug-free pain management therapies
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost of advanced electrotherapy devices
      • 3.2.2.2. Limited clinical evidence and skepticism among healthcare professionals
    • 3.2.3. Market Opportunity Analysis
      • 3.2.3.1. Integration of AI and IoT in electrotherapy devices
      • 3.2.3.2. Rising demand in home-based rehabilitation and telehealth settings
    • 3.2.4. Market Challenge Analysis
      • 3.2.4.1. Stringent quality and safety standards
  • 3.3. U.S. Electrotherapy Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. U.S. Electrotherapy Market: Therapy Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Electrotherapy Market Therapy Type Movement Analysis
  • 4.3. U.S. Electrotherapy Market Size & Trend Analysis, by Therapy Type 2021 to 2033 (USD Million)
  • 4.4. Transcutaneous Electrical Nerve Stimulation (TENS)
    • 4.4.1. Transcutaneous Electrical Nerve Stimulation (TENS) Market Estimates and Forecasts for 2021 to 2033 (USD Million)
  • 4.5. Interferential Therapy (IFT)
    • 4.5.1. Interferential Therapy (IFT) Market Estimates and Forecasts for 2021 to 2033 (USD Million)
  • 4.6. NMES/FES
    • 4.6.1. NMES/FES Market Estimates and Forecasts for 2021 to 2033 (USD Million)
  • 4.7. Others
    • 4.7.1. Others Market Estimates and Forecasts for 2021 to 2033 (USD Million)

Chapter 5. U.S. Electrotherapy Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Electrotherapy Market Application Movement Analysis
  • 5.3. U.S. Electrotherapy Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 5.4. Nervous Disease
    • 5.4.1. Nervous Disease Market Estimates and Forecasts for 2021 to 2033 (USD Million)
  • 5.5. Muscle Injury
    • 5.5.1. Muscle Injury Market Estimates and Forecasts for 2021 to 2033 (USD Million)
  • 5.6. Inflammation
    • 5.6.1. Inflammation Market Estimates and Forecasts for 2021 to 2033 (USD Million)
  • 5.7. Pain Relief
    • 5.7.1. Pain Relief Market Estimates and Forecasts for 2021 to 2033 (USD Million)
  • 5.8. Others
    • 5.8.1. Others Market Estimates and Forecasts for 2021 to 2033 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Company/Competition Categorization
    • 6.2.1. Innovators
  • 6.3. Vendor Landscape
    • 6.3.1. Key company market share analysis, 2024
    • 6.3.2. Zynex Medical
      • 6.3.2.1. Company overview
      • 6.3.2.2. Financial performance
      • 6.3.2.3. Usage benchmarking
      • 6.3.2.4. Strategic initiatives
    • 6.3.3. BTL Group of Companies
      • 6.3.3.1. Company overview
      • 6.3.3.2. Financial performance
      • 6.3.3.3. Usage benchmarking
      • 6.3.3.4. Strategic initiatives
    • 6.3.4. Omron Healthcare, Inc.
      • 6.3.4.1. Company overview
      • 6.3.4.2. Financial performance
      • 6.3.4.3. Usage benchmarking
      • 6.3.4.4. Strategic initiatives
    • 6.3.5. NeuroMetrix, Inc.
      • 6.3.5.1. Company overview
      • 6.3.5.2. Financial performance
      • 6.3.5.3. Usage benchmarking
      • 6.3.5.4. Strategic initiatives
    • 6.3.6. GymnaUniphy
      • 6.3.6.1. Company overview
      • 6.3.6.2. Financial performance
      • 6.3.6.3. Usage benchmarking
      • 6.3.6.4. Strategic initiatives
    • 6.3.7. Enovis Corporation
      • 6.3.7.1. Company overview
      • 6.3.7.2. Financial performance
      • 6.3.7.3. Usage benchmarking
      • 6.3.7.4. Strategic initiatives
    • 6.3.8. Medtronic
      • 6.3.8.1. Company overview
      • 6.3.8.2. Financial performance
      • 6.3.8.3. Usage benchmarking
      • 6.3.8.4. Strategic initiatives
    • 6.3.9. Omron Healthcare, Inc.
      • 6.3.9.1. Company overview
      • 6.3.9.2. Financial performance
      • 6.3.9.3. Usage benchmarking
      • 6.3.9.4. Strategic initiatives
    • 6.3.10. Dentis Co., Ltd.
      • 6.3.10.1. Company overview
      • 6.3.10.2. Financial performance
      • 6.3.10.3. Usage benchmarking
      • 6.3.10.4. Strategic initiatives
    • 6.3.11. Stymco
      • 6.3.11.1. Company overview
      • 6.3.11.2. Financial performance
      • 6.3.11.3. Usage benchmarking
      • 6.3.11.4. Strategic initiatives
    • 6.3.12. RS Medical
      • 6.3.12.1. Company overview
      • 6.3.12.2. Financial performance
      • 6.3.12.3. Usage benchmarking
      • 6.3.12.4. Strategic initiatives
    • 6.3.13. Orthofix Medical
      • 6.3.13.1. Company overview
      • 6.3.13.2. Financial performance
      • 6.3.13.3. Usage benchmarking
      • 6.3.13.4. Strategic initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. U.S. electrotherapy market, by country, 2021 - 2033 (USD Million)
  • Table 4. U.S. electrotherapy market, by therapy type, 2021 - 2033 (USD Million)
  • Table 5. U.S. electrotherapy market, by application, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 U.S. Electrotherapy Market, Market Segmentation
  • Fig. 7 Market Driver Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Analysis (Current & Future Impact)
  • Fig. 9 Market Opportunity Analysis (Current & Future Impact)
  • Fig. 10 Market Challenge Analysis (Current & Future Impact)
  • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 12 Porter's Five Forces Analysis
  • Fig. 13 Electrotherapy Market: Therapy Type Movement Analysis
  • Fig. 14 Transcutaneous Electrical Nerve Stimulation (TENS) Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 15 Interferential Therapy (IFT) Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 16 NMES/FES Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 17 Others Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 18 Dental Implant Market: Application Movement Analysis
  • Fig. 19 Nervous Disease Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 20 Muscle Injury Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 21 Inflammation Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 22 Pain Relief Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 23 Others Market Estimates and Forecast, 2021 - 2033 (USD Million)